Internal Steering Committee Emeriti

Professor Clawson’s research focuses on American politics, especially public opinion; the mass media; the politics of race, class, and gender; and the ethical, legal, and social implications of technology. Her research has been funded by the National Science Foundation, the Mellon Foundation, and the USDA. She is the Director of Diversity and Culture of Inclusion for Advancing Sustainability through Powered Infrastructure for Roadway Electrification, ASPIRE NSF Engineering Research Center.

Professor Huber developed a new treatment for individuals with Parkinson's disease which will allow treatment to take place in everyday communication environments, rather than in the clinic, increasing the generalization of improved communication to patient's daily life even for those with moderate to severe impairments. This treatment involves the use of a small wearable device called the SpeechVive which cues patients to talk louder and clearer through the use of the Lombard Effect. She demonstrated its effectiveness in a two-site clinical efficacy study and patented the technology. Due her efforts in commercialization with assistance from partners at Purdue University, the SpeechVive will be on the market in 2013. Professor Huber is also examining how communication and treatment gains are affected by other common tasks (for example, how speech and language production change when a person is walking and talking, rather than just sitting and talking). To achieve this research goal, Dr. Huber collaborates with other researchers in the areas of linguistics, balance, gait, and psychosocial factors along with neurologists, speech therapists, and physical therapists. Professor Huber was recently named as the Burton D. Morgan Entrepreneur in Residence at Discovery Park. As the Entrepreneur in Residence, she assists other faculty and students who are working to translate or commercialize their ideas. She works with the leaders and staff from Discovery Park to improve the pipeline for research to impact the Indiana and U.S. economy.

Controlled Drug Delivery, Bio-nanotechnology, Tissue Engineering
Professor Yeo's research focuses on developing new drug delivery systems and biomaterials enabling safe, efficient, and clinically viable delivery of drugs, genes and/or cells in a target-specific manner. In particular, Professor yeo is interested in developing drug formulations that will enhance site-specific drug distribution for therapy of tumors or chronic pulmonary diseases.